A Study of Topical Arnica & Ledum on Bruise Reduction in HNV

C

Cearna

Status

Unknown

Conditions

Bruise, Contusion

Treatments

Other: Arnica montana, Ledum palustre

Study type

Interventional

Funder types

Industry

Identifiers

NCT04533269
CI-B001

Details and patient eligibility

About

Subjects will have a bruise induced. A pad containing either a placebo or active will be applied to the bruise. Photographs will be taken over the following days to record bruise healing.

Full description

This is a randomized, double-blind, placebo-controlled, crossover, multicenter study that will be used to evaluate the difference in bruise reduction efficacy between active remedy and placebo when a mechanical bruise is induced. The trial will be conducted at 5-8 sites with up to 150 subjects. Each subject will be injured two times using the same bruise-inducing mechanism, and the resulting bruises will be treated with active remedy or placebo-infused pads that will be identical in appearance. Subjects and study investigators will be blinded to the order of treatment assignment. Subjects will be asked to come to the clinic for photographic assessments of the bruise. Each subject will be randomly assigned to have a placebo or active remedy pad applied over each mechanically induced bruise on Day 1. The pad will be applied by study staff immediately after bruise induction (within 5 minutes). The pad will cover the bruised area completely, and then sealed with Tegaderm. All procedures, including bruise induction, treatment, and photography, will be administered by study staff who are blinded to treatment type. All photographs will be rated according to standardized criteria by blinded, trained study investigators after the completion of all subject data collection.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Fitzpatrick skin type 1-3
  • BMI 25 kg/m2
  • Self described bruisers
  • Intact skin in the target area, free of markings, blemishes and hair

Exclusion criteria

  • Use of recreational drugs, steroids, pain medications, other homeopathic remedies, anticoagulant therapies, antiplatelet therapy
  • Known history of dermal sensitivity, serious illness, hematological abnormality, impaired wound healing
  • Inability to forego application of topical products in the target area
  • Hair removal by laser, wax or chemicals within one week prior to Day 1
  • Avoid tanning beds
  • History of allergy to topical gels, Arnica or Ledum
  • Active wound or infection in the target area
  • History of keloids or hypertrophic scarring
  • History of collagen or vascular disease
  • History of organ transplant

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

150 participants in 2 patient groups, including a placebo group

Active
Experimental group
Description:
Arnica montana and Ledum palustre infused Pad
Treatment:
Other: Arnica montana, Ledum palustre
Placebo
Placebo Comparator group
Description:
Pad (Matching appearance with Active)
Treatment:
Other: Arnica montana, Ledum palustre

Trial contacts and locations

0

Loading...

Central trial contact

Jacqueline Blem

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems